In an article published today in Frontiers in Immunology, Immune Tolerance Network (ITN) leadership and clinical trial physicians review ITN's approach to the development of therapies that aim to establish tolerance in immune mediated diseases. They present concepts that have evolved from the ITN's clinical trial experience, with an emphasis on lessons learned from the mechanistic studies conducted as a part of these trials and strategies under development for the induction of tolerance.
